Dynasore TCI D5461

Chemical Identity

Other names: 3-Hydroxynaphthalene-2-carboxylic Acid (3,4-Dihydroxybenzylidene)hydrazide · N'-(3,4-Dihydroxybenzylidene)-3-hydroxy-2-naphthohydrazide
CAS No.: 304448-55-3
PubChem: CID 708101·SID 354335629
Formula: C18H14N2O4
Molecular weight: 322.32 g/mol
Purity: >90.0%(HPLC)
Storage: <0°C

Full identifiers (IUPAC, SMILES, InChIKey)

IUPAC: N-[(3,4-dihydroxyphenyl)methylideneamino]-3-hydroxynaphthalene-2-carboxamide
SMILES: C1=CC=C2C=C(C(=CC2=C1)C(=O)NN=CC3=CC(=C(C=C3)O)O)O
InChIKey: SYNDQCRDGGCQRZ-UHFFFAOYSA-N
MDL: MDL00292551

Rp 2.889.600,00

Sale Sold out

Shipping calculated at checkout.

Berat 10mg 50mg

Pembayaran hanya melalui request quotation dan dilakukan setelah tim kami menghubungi Anda. Mohon cantumkan nomor WhatsApp aktif untuk konfirmasi pesanan & pembuatan invoice. Estimasi pengiriman 2-4 minggu setelah pembayaran.

Dokumen Keamanan & Mutu

↓ Unduh SDS / MSDS (PDF resmi TCI)

CoA (Certificate of Analysis)

Spesifik per batch produksi — diterbitkan dan dikirim bersama barang sesuai nomor lot yang Anda terima.

Contoh CoA segera tersedia.

💬 Minta CoA via WhatsApp

View full details

Dynasore (CAS 304448-55-3) is a high-quality chemical from TCI, supplied as HPLC Grade.

Application: Synthesis reagent for a wide range of organic chemistry transformations in laboratory and industrial settings.

Specifications:

Molecular formula: C18H14N2O4
CAS number: 304448-55-3
Purity: >90.0%(HPLC)
TCI product code: D5461

Synonyms: 3-Hydroxynaphthalene-2-carboxylic Acid (3,4-Dihydroxybenzylidene)hydrazide; N'-(3,4-Dihydroxybenzylidene)-3-hydroxy-2-naphthohydrazide

Available from AMI Scientific, the authorised TCI distributor in Indonesia. Contact us for pricing and stock availability — we ship throughout Indonesia.

TCI brochures (PDF)

Exosome Inhibitors 2025-09-05 · p. 1

Related TCI products

—

Brand	—
CAS number	—
Molecular formula	—
Purity	—
Category	—
Pack sizes	—
Physical form	—
Storage	—

—

References cited in the TCI brochure

Jong Hyun Kim. Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer Experimental & Molecular Medicine, 2022. doi:10.1038/s12276-022-00898-7